IN RE: Tepezza Marketing, Sales Practices, and Products Liability Litigation

  1. June 05, 2023

    JPML Consolidates Thyroid Drug Hearing-Loss Suits In Illinois

    The U.S. Judicial Panel on Multidistrict Litigation has decided to consolidate 18 suits accusing Horizon Pharmaceuticals Inc. of not telling patients a drug it developed to treat thyroid eye disease can cause permanent hearing damage.

  2. May 24, 2023

    On Deck In JPML: FTX, Cheer Abuse, T-Mobile

    The Judicial Panel on Multidistrict Litigation on Thursday will consider whether to centralize sprawling fallout from the collapse of crypto exchange FTX, as well as claims of hearing loss from the drug Tepezza and allegedly exploding solar panel systems.